Skip to main content
Clinical Trials/NCT00071292
NCT00071292CompletedPhase 2

Mindfulness Meditation-Based Stress Reduction in Relieving Symptoms Associated With Rheumatoid Arthritis

National Center for Complementary and Integrative Health (NCCIH)2 sites in 1 country80 target enrollmentStarted: July 1, 2003Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
80
Locations
2

Study Overview

Brief Summary

The purpose of this study is to determine whether a mindfulness meditation-based stress reduction program is useful in relieving symptoms associated with rheumatoid arthritis (RA).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Confirmed diagnosis of RA, with doctor's letter or doctors' bill with ICD code 714;
  • 18 years of age or older;
  • Able to read and write English;
  • Able to attend 15 course sessions and questionnaire sessions at Kernan Hospital in Baltimore;
  • Willing to practice skills for 45 minutes to 1 hour per day, 6 days a week;
  • Stable on rheumatoid medications for at least one month.

Exclusion Criteria

  • Major psychiatric illness (bipolar disorder, multiple personality disorder, etc.);
  • Active alcoholism or drug dependency;
  • Scheduled for major surgery during the study period;
  • Enrolled in randomized clinical trial for rheumatoid arthritis during the study period;
  • Planning to move out of the area in the next 12 months;
  • Unwilling to be enrolled in a control group;
  • Use of assistive device other than a cane;
  • Serious health condition(s) that the investigator determines would make it difficult to complete the 6 month study;
  • Diagnosis of fibromyalgia.

Investigators

Study Sites (2)

Loading locations...

Similar Trials

Meditation-Based Stress Reduction in... | Clinical Trial